vs

Side-by-side financial comparison of Crown Castle (CCI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.0B, roughly 1.5× Crown Castle). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -45.9%, a 50.4% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs -4.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $-43.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -4.5%).

Crown Castle Inc. is a real estate investment trust and provider of shared communications infrastructure in the United States headquartered in Houston, Texas. Operating with 100 offices worldwide, its network includes over 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber systems.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

CCI vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.5× larger
ONC
$1.5B
$1.0B
CCI
Growing faster (revenue YoY)
ONC
ONC
+37.6% gap
ONC
32.8%
-4.8%
CCI
Higher net margin
ONC
ONC
50.4% more per $
ONC
4.4%
-45.9%
CCI
More free cash flow
ONC
ONC
$422.8M more FCF
ONC
$379.8M
$-43.0M
CCI
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
-4.5%
CCI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CCI
CCI
ONC
ONC
Revenue
$1.0B
$1.5B
Net Profit
$-464.0M
$66.5M
Gross Margin
90.5%
Operating Margin
46.0%
12.4%
Net Margin
-45.9%
4.4%
Revenue YoY
-4.8%
32.8%
Net Profit YoY
143.8%
EPS (diluted)
$1.48
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCI
CCI
ONC
ONC
Q1 26
$1.0B
Q4 25
$1.1B
$1.5B
Q3 25
$1.1B
$1.4B
Q2 25
$1.1B
$1.3B
Q1 25
$1.1B
$1.1B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$1.0B
Q2 24
$1.1B
$929.2M
Net Profit
CCI
CCI
ONC
ONC
Q1 26
$-464.0M
Q4 25
$294.0M
$66.5M
Q3 25
$323.0M
$124.8M
Q2 25
$291.0M
$94.3M
Q1 25
$-464.0M
$1.3M
Q4 24
$-151.9M
Q3 24
$303.0M
$-121.3M
Q2 24
$251.0M
$-120.4M
Gross Margin
CCI
CCI
ONC
ONC
Q1 26
Q4 25
97.4%
90.5%
Q3 25
97.2%
86.1%
Q2 25
97.5%
87.5%
Q1 25
97.4%
85.2%
Q4 24
97.7%
85.8%
Q3 24
97.6%
83.0%
Q2 24
97.7%
85.1%
Operating Margin
CCI
CCI
ONC
ONC
Q1 26
46.0%
Q4 25
48.8%
12.4%
Q3 25
49.0%
11.5%
Q2 25
47.7%
6.7%
Q1 25
49.1%
1.0%
Q4 24
51.0%
-7.0%
Q3 24
47.5%
-12.0%
Q2 24
44.7%
-11.5%
Net Margin
CCI
CCI
ONC
ONC
Q1 26
-45.9%
Q4 25
27.5%
4.4%
Q3 25
30.1%
8.8%
Q2 25
27.5%
7.2%
Q1 25
-43.7%
0.1%
Q4 24
-13.5%
Q3 24
27.1%
-12.1%
Q2 24
22.7%
-13.0%
EPS (diluted)
CCI
CCI
ONC
ONC
Q1 26
$1.48
Q4 25
$0.67
$0.05
Q3 25
$0.74
$0.08
Q2 25
$0.67
$0.06
Q1 25
$-1.07
$0.00
Q4 24
$-0.10
Q3 24
$0.70
$-0.09
Q2 24
$0.58
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCI
CCI
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$55.0M
$4.5B
Total DebtLower is stronger
$836.4M
Stockholders' EquityBook value
$4.4B
Total Assets
$31.4B
$8.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCI
CCI
ONC
ONC
Q1 26
$55.0M
Q4 25
$99.0M
$4.5B
Q3 25
$57.0M
$4.0B
Q2 25
$94.0M
$2.8B
Q1 25
$60.0M
$2.5B
Q4 24
$100.0M
$2.6B
Q3 24
$194.0M
$2.7B
Q2 24
$155.0M
$2.6B
Total Debt
CCI
CCI
ONC
ONC
Q1 26
Q4 25
$21.6B
$836.4M
Q3 25
$21.6B
Q2 25
$22.0B
Q1 25
$22.9B
Q4 24
$23.5B
Q3 24
$23.5B
Q2 24
$22.9B
Stockholders' Equity
CCI
CCI
ONC
ONC
Q1 26
Q4 25
$-1.6B
$4.4B
Q3 25
$-1.5B
$4.1B
Q2 25
$-1.4B
$3.8B
Q1 25
$-1.3B
$3.5B
Q4 24
$-133.0M
$3.3B
Q3 24
$5.3B
$3.4B
Q2 24
$5.7B
$3.4B
Total Assets
CCI
CCI
ONC
ONC
Q1 26
$31.4B
Q4 25
$31.5B
$8.2B
Q3 25
$31.5B
$7.6B
Q2 25
$31.6B
$6.3B
Q1 25
$31.8B
$5.8B
Q4 24
$32.7B
$5.9B
Q3 24
$38.0B
$5.8B
Q2 24
$38.2B
$5.7B
Debt / Equity
CCI
CCI
ONC
ONC
Q1 26
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
4.43×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCI
CCI
ONC
ONC
Operating Cash FlowLast quarter
$417.3M
Free Cash FlowOCF − Capex
$-43.0M
$379.8M
FCF MarginFCF / Revenue
-4.3%
25.4%
Capex IntensityCapex / Revenue
1.0%
2.5%
Cash ConversionOCF / Net Profit
6.28×
TTM Free Cash FlowTrailing 4 quarters
$4.3B
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCI
CCI
ONC
ONC
Q1 26
Q4 25
$3.1B
$417.3M
Q3 25
$714.0M
$402.6M
Q2 25
$832.0M
$263.6M
Q1 25
$641.0M
$44.1M
Q4 24
$2.9B
$75.2M
Q3 24
$699.0M
$188.4M
Q2 24
$768.0M
$-95.6M
Free Cash Flow
CCI
CCI
ONC
ONC
Q1 26
$-43.0M
Q4 25
$2.9B
$379.8M
Q3 25
$671.0M
$354.5M
Q2 25
$792.0M
$219.8M
Q1 25
$601.0M
$-12.3M
Q4 24
$2.8B
$-17.3M
Q3 24
$661.0M
$54.7M
Q2 24
$729.0M
$-205.5M
FCF Margin
CCI
CCI
ONC
ONC
Q1 26
-4.3%
Q4 25
268.4%
25.4%
Q3 25
62.6%
25.1%
Q2 25
74.7%
16.7%
Q1 25
56.6%
-1.1%
Q4 24
247.3%
-1.5%
Q3 24
59.0%
5.5%
Q2 24
65.9%
-22.1%
Capex Intensity
CCI
CCI
ONC
ONC
Q1 26
1.0%
Q4 25
17.0%
2.5%
Q3 25
4.0%
3.4%
Q2 25
3.8%
3.3%
Q1 25
3.8%
5.0%
Q4 24
15.7%
8.2%
Q3 24
3.4%
13.3%
Q2 24
3.5%
11.8%
Cash Conversion
CCI
CCI
ONC
ONC
Q1 26
Q4 25
10.40×
6.28×
Q3 25
2.21×
3.22×
Q2 25
2.86×
2.79×
Q1 25
34.71×
Q4 24
Q3 24
2.31×
Q2 24
3.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCI
CCI

Site rental$961.0M95%
Services and other$49.0M5%

ONC
ONC

Segment breakdown not available.

Related Comparisons